Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Led by the Centre for Evidence-Based Medicine, and jointly run by the Department for Continuing Education, this summer school invites EBHC students, supervisors, consumers, and leading evidence-based experts into the surroundings of Kellogg College, University of Oxford. 4-20 July. Spanning three weeks this unique experience offers: EBHC modules; non-accredited short courses; a selection of workshops and EBMLive 2022.

Close up of the Radcliffe Camera on a sunny day with a blossom tree in front. © Shutterstock

The aim of this summer school is to foster debate and engage with like-minded colleagues while offering additional learning relevant to evidence-based health care post pandemic.

During this event, dinners, lunches and other social events will be hosted.

Each summer school event must be registered for individually, enabling attendees to pick and choose which events they wish to attend. Concession rates are available upon registration for students in Medical and Health Sciences and Evidence-Based Health Care alumni (excluding the accredited module)

Find out more about the summer school on the Centre for Evidence-Based Medicine website. 

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.